Danielle Porter
- Infectious Diseases top 0.2%
- SARS-CoV-2 and COVID-19 Research 23
- HIV/AIDS drug development and treatment 20
- COVID-19 Clinical Research Studies 13
- HIV/AIDS Research and Interventions 13
- Viral Infections and Outbreaks Research 10
- Viral Infections and Vectors 8
- Virology top 1%
- HIV Research and Treatment 16
- Neurology top 2%
- Modeling and Simulation top 5%
-
- Respiratory viral infections research 8
- Co-authors
- Joy Y. FengMatthias GötteEgor P. TchesnokovCalvin J. GordonJason K. PerryEmma WoolnerTomáš CihlářDarius Babusis
- Cited by
- Infectious DiseasesVirologyNeurology
- Journals
- Journal of Biological Chemistry (5 papers)Antimicrobial Agents and Chemotherapy (5 papers)Antiviral Research (5 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Danielle Porter
56 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Infectious Diseases 3.8k
- Virology 481
- Neurology 601
- Computational Theory and Mathematics 493
- Modeling and Simulation 96
Countries citing papers authored by Danielle Porter
This map shows the geographic impact of Danielle Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Porter more than expected).
Fields of papers citing papers by Danielle Porter
This network shows the impact of papers produced by Danielle Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Porter. The network helps show where Danielle Porter may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Danielle Porter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 6 | |
| 4 | 2022 | 25 | |
| 5 | Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanismsbreakdown → | 2022 | 139 |
| 6 | 2022 | 6 | |
| 7 | 2022 | 48 | |
| 8 | 2022 | 5 | |
| 9 | 2021 | 93 | |
| 10 | 2021 | 31 | |
| 11 | 2021 | 56 | |
| 12 | 2020 | 50 | |
| 13 | 2020 | 45 | |
| 14 | Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potencybreakdown → | 2020 | 698 |
| 15 | 2020 | 117 | |
| 16 | 2017 | 37 | |
| 17 | 2016 | 18 | |
| 18 | 2013 | 20 | |
| 19 | 2013 | 2 | |
| 20 | 2013 | 92 |
About Danielle Porter
Danielle Porter is a scholar working on Virology, Infectious Diseases, Emergency Medical Services, Epidemiology and Cardiology and Cardiovascular Medicine, having authored 59 papers that have together received 4.5k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (23 papers), HIV/AIDS drug development and treatment (20 papers), HIV Research and Treatment (16 papers), COVID-19 Clinical Research Studies (13 papers), HIV/AIDS Research and Interventions (13 papers), Viral Infections and Outbreaks Research (10 papers), Respiratory viral infections research (8 papers) and Viral Infections and Vectors (8 papers). The work is most often cited by research in Infectious Diseases (3.8k citations), Virology (481 citations), Neurology (601 citations), Computational Theory and Mathematics (493 citations) and Modeling and Simulation (96 citations). Danielle Porter has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Joy Y. Feng, Matthias Götte, Egor P. Tchesnokov, Calvin J. Gordon, Jason K. Perry, Emma Woolner, Tomáš Cihlář, Darius Babusis, Timothy P. Sheahan and Ralph S. Baric. Their work appears in journals such as Journal of Biological Chemistry, Antimicrobial Agents and Chemotherapy, Antiviral Research, The Journal of Infectious Diseases and AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.